1. Home
  2. WAT vs RIVN Comparison

WAT vs RIVN Comparison

Compare WAT & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • RIVN
  • Stock Information
  • Founded
  • WAT 1958
  • RIVN 2009
  • Country
  • WAT United States
  • RIVN United States
  • Employees
  • WAT N/A
  • RIVN N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • RIVN Auto Manufacturing
  • Sector
  • WAT Industrials
  • RIVN Consumer Discretionary
  • Exchange
  • WAT Nasdaq
  • RIVN Nasdaq
  • Market Cap
  • WAT 17.0B
  • RIVN 15.4B
  • IPO Year
  • WAT 1995
  • RIVN 2021
  • Fundamental
  • Price
  • WAT $291.56
  • RIVN $12.24
  • Analyst Decision
  • WAT Hold
  • RIVN Hold
  • Analyst Count
  • WAT 14
  • RIVN 21
  • Target Price
  • WAT $374.07
  • RIVN $14.00
  • AVG Volume (30 Days)
  • WAT 1.0M
  • RIVN 41.2M
  • Earning Date
  • WAT 08-04-2025
  • RIVN 08-05-2025
  • Dividend Yield
  • WAT N/A
  • RIVN N/A
  • EPS Growth
  • WAT 10.77
  • RIVN N/A
  • EPS
  • WAT 11.09
  • RIVN N/A
  • Revenue
  • WAT $3,046,056,000.00
  • RIVN $5,151,000,000.00
  • Revenue This Year
  • WAT $6.27
  • RIVN $6.92
  • Revenue Next Year
  • WAT $6.49
  • RIVN $37.66
  • P/E Ratio
  • WAT $26.30
  • RIVN N/A
  • Revenue Growth
  • WAT 5.89
  • RIVN 2.73
  • 52 Week Low
  • WAT $275.05
  • RIVN $9.50
  • 52 Week High
  • WAT $423.56
  • RIVN $17.15
  • Technical
  • Relative Strength Index (RSI)
  • WAT 44.31
  • RIVN 43.42
  • Support Level
  • WAT $278.49
  • RIVN $11.79
  • Resistance Level
  • WAT $296.89
  • RIVN $12.35
  • Average True Range (ATR)
  • WAT 7.48
  • RIVN 0.48
  • MACD
  • WAT 2.68
  • RIVN -0.02
  • Stochastic Oscillator
  • WAT 53.76
  • RIVN 29.65

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About RIVN Rivian Automotive Inc.

Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.

Share on Social Networks: